Dowling & Yahnke’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,000
| Closed | -$112K | – | 369 |
|
|
2021
Q1 | $112K | Sell |
11,000
-5,000
| -31% | -$50.9K | 0.01% | 333 |
|
|
2020
Q4 | $119K | Hold |
16,000
| – | – | 0.01% | 321 |
|
|
2020
Q3 | $55K | Buy |
16,000
+5,000
| +45% | +$17.2K | ﹤0.01% | 303 |
|
|
2020
Q2 | $52K | Hold |
11,000
| – | – | ﹤0.01% | 290 |
|
|
2020
Q1 | $22K | Buy |
+11,000
| New | +$22K | ﹤0.01% | 288 |
|